Market Cap 1,113.78B
Revenue (ttm) 65.18B
Net Income (ttm) 20.64B
EPS (ttm) N/A
PE Ratio 37.48
Forward PE 32.46
Profit Margin 31.67%
Debt to Equity Ratio 1.62
Volume 2,509,000
Avg Vol 2,881,942
Day's Range N/A - N/A
Shares Out 941.36M
Stochastic %K 82%
Beta 0.51
Analysts Strong Sell
Price Target $1,331.75

Company Profile

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 317 276 2000
Address:
Lilly Corporate Center, Indianapolis, United States
Kenan123
Kenan123 Aug. 19 at 11:31 AM
$PNGAF The Precision Peptide Company Inc. Announces Development of Needle-Free Tirzepatide Transdermal Patch: https://finance.yahoo.com/healthcare/articles/precision-peptide-company-inc-announces-110000856.html A dig on $LLY I like it
0 · Reply
Stewietradeer
Stewietradeer Aug. 19 at 11:23 AM
🔥 $TGT — Key earnings-day watch. Shares closed Tuesday around $152.48, +1%, after a roughly 56% YTD rally. Q2 results are due before the open, with analysts looking for about $2.34 EPS and $26.09B revenue. ⚡ $ADI — Major semiconductor earnings event today. Analysts expect roughly $3.34 adjusted EPS and $3.92B revenue, with options implying a move of up to about 6% around earnings. AI infrastructure demand is a key focus. 💊 $LLY — Healthcare remains a relative-strength area after Tuesday's tech selloff 🛢️ $OKE — Energy continues to attract attention as Brent crude remains above $90/barrel, keeping oil-and-gas names relatively strong while broader markets deal with geopolitical and inflation concerns. ⚠️ Risk: Tuesday's semiconductor selloff and elevated Treasury yields show that momentum can reverse quickly. Earnings names could see especially large moves today, so avoid chasing extended moves. #Stocks #StockMarket #Momentum #Earnings #TGT #LOW #ADI #LLY #OKE #Trading
0 · Reply
Quantumup
Quantumup Aug. 19 at 11:20 AM
BMO Capital🏁 $BCAX and said -- We are initiating coverage of Bicara Therapeutics with an Outperform rating and $35 target price. MRUS - $GMAB $LLY MRK BMY AZN INCY BMO Capital added—Bicara's bispecific, ficerafusp alfa, is a differentiated HNSCC asset with the potential to deliver broader, deeper, and more durable responses. The pivotal FORTIFI-HN01 interim analysis in mid-2027 is the key value inflection point, wherein a clear translation of strong Ph 1b activity indicates a strong market positioning, paving a path to accelerated approval in 2028 for a ~$2 billion peak sales opportunity. Other solid tumor opportunities, including mCRC, can provide additional upside potential.
0 · Reply
LLYBULL
LLYBULL Aug. 19 at 11:19 AM
$LLY Looks like LLY will be making new All Time Highs today! Go LLY, Fly like an Eagle!
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 19 at 10:38 AM
Novo Nordisk Begins New Study Testing Smaller Doses Of Blockbuster Wegovy – A Look At Some Key Highlights $NVO $LLY $OZEM https://stocktwits.com/news/equity/markets/novo-nordisk-looks-to-expand-wegovy-pill-push-with-lower-dose-study/cZYdgkhRJkA
0 · Reply
ChristineMartinez757
ChristineMartinez757 Aug. 19 at 9:15 AM
$HGRAF $KORU $LLY $HIMS HGRAF remains highly speculative, KORU remains speculative and execution-dependent, Eli Lilly benefits from strong obesity and diabetes-drug demand, and Hims & Hers benefits from digital-health adoption. I'm watching liquidity, prescription growth, customer additions, regulatory developments, and margins.
0 · Reply
WalterLind399
WalterLind399 Aug. 19 at 9:10 AM
$SGML $STLA $LLY $XLE Sigma Lithium remains tied to lithium development, Stellantis remains focused on global auto demand, Eli Lilly benefits from obesity and diabetes-drug demand, and XLE provides diversified energy exposure. I'm watching lithium prices, vehicle volumes, prescription growth, oil prices, and margins.
0 · Reply
TamiDungan690
TamiDungan690 Aug. 19 at 7:12 AM
$SGML $STLA $LLY $XLE Sigma Lithium remains tied to lithium development, Stellantis remains focused on global auto demand, Eli Lilly benefits from obesity and diabetes-drug demand, and XLE provides diversified energy exposure. I'm watching lithium prices, vehicle volumes, prescription growth, oil prices, and margins.
1 · Reply
RaulCole522
RaulCole522 Aug. 19 at 7:09 AM
$HGRAF $KORU $LLY $HIMS HGRAF remains highly speculative, KORU remains speculative and execution-dependent, Eli Lilly benefits from strong obesity and diabetes-drug demand, and Hims & Hers benefits from digital-health adoption. I'm watching liquidity, prescription growth, customer additions, regulatory developments, and margins.
0 · Reply
Johnny_Lever
Johnny_Lever Aug. 19 at 5:55 AM
$LLY Getting ready to re-test that ATH.
0 · Reply
Latest News on LLY
Novo Nordisk CEO Defends Lawsuit Against Eli Lilly (LLY)

2026-08-13T14:52:11.000Z - 5 days ago

Novo Nordisk CEO Defends Lawsuit Against Eli Lilly (LLY)

NVO


Eli Lilly Sues Sellers of Black Market Weight-Loss Drugs

Aug 12, 2026, 7:39 AM EDT - 6 days ago

Eli Lilly Sues Sellers of Black Market Weight-Loss Drugs


UK green lights Lilly's obesity pill

Aug 10, 2026, 7:39 AM EDT - 8 days ago

UK green lights Lilly's obesity pill


Eli Lilly price target raised to $1,376 from $1,370 at Truist

2026-08-07T14:10:33.000Z - 11 days ago

Eli Lilly price target raised to $1,376 from $1,370 at Truist


Eli Lilly (LLY) Stock Remains a Buy after Q2

2026-08-07T12:49:00.000Z - 11 days ago

Eli Lilly (LLY) Stock Remains a Buy after Q2


Inside Out: LLY and the Future of Weight Loss Drugs

Aug 5, 2026, 12:00 PM EDT - 13 days ago

Inside Out: LLY and the Future of Weight Loss Drugs


Eli Lilly and Company Earnings Call Transcript: Q2 2026

Aug 5, 2026, 10:00 AM EDT - 13 days ago

Eli Lilly and Company Earnings Call Transcript: Q2 2026


Eli Lilly and Company Slides: Q2 2026

Aug 5, 2026, 10:00 AM EDT - 13 days ago

Eli Lilly and Company Slides: Q2 2026


Eli Lilly and Company Earnings release: Q2 2026

Aug 5, 2026, 10:00 AM EDT - 13 days ago

Eli Lilly and Company Earnings release: Q2 2026


Eli Lilly and Company Quarterly report: Q2 2026

Aug 5, 2026, 10:00 AM EDT - 13 days ago

Eli Lilly and Company Quarterly report: Q2 2026


Eli Lilly Posts Higher Revenue on Continued GLP-1 Demand

Aug 5, 2026, 7:19 AM EDT - 14 days ago

Eli Lilly Posts Higher Revenue on Continued GLP-1 Demand


Lilly's revenue soars 48%, driven by demand of its GLP-1s

Aug 5, 2026, 7:04 AM EDT - 14 days ago

Lilly's revenue soars 48%, driven by demand of its GLP-1s


Lilly's Next-Generation Obesity Shot Clears Another Hurdle

Jul 23, 2026, 7:25 PM EDT - 26 days ago

Lilly's Next-Generation Obesity Shot Clears Another Hurdle


Weight loss drugs linked to increase risk of hair loss

Jul 22, 2026, 8:57 PM EDT - 27 days ago

Weight loss drugs linked to increase risk of hair loss

NVO


Hair loss with GLP-1 drugs is rare, but real, studies find

Jul 22, 2026, 6:31 PM EDT - 27 days ago

Hair loss with GLP-1 drugs is rare, but real, studies find

AZN NVO


Kenan123
Kenan123 Aug. 19 at 11:31 AM
$PNGAF The Precision Peptide Company Inc. Announces Development of Needle-Free Tirzepatide Transdermal Patch: https://finance.yahoo.com/healthcare/articles/precision-peptide-company-inc-announces-110000856.html A dig on $LLY I like it
0 · Reply
Stewietradeer
Stewietradeer Aug. 19 at 11:23 AM
🔥 $TGT — Key earnings-day watch. Shares closed Tuesday around $152.48, +1%, after a roughly 56% YTD rally. Q2 results are due before the open, with analysts looking for about $2.34 EPS and $26.09B revenue. ⚡ $ADI — Major semiconductor earnings event today. Analysts expect roughly $3.34 adjusted EPS and $3.92B revenue, with options implying a move of up to about 6% around earnings. AI infrastructure demand is a key focus. 💊 $LLY — Healthcare remains a relative-strength area after Tuesday's tech selloff 🛢️ $OKE — Energy continues to attract attention as Brent crude remains above $90/barrel, keeping oil-and-gas names relatively strong while broader markets deal with geopolitical and inflation concerns. ⚠️ Risk: Tuesday's semiconductor selloff and elevated Treasury yields show that momentum can reverse quickly. Earnings names could see especially large moves today, so avoid chasing extended moves. #Stocks #StockMarket #Momentum #Earnings #TGT #LOW #ADI #LLY #OKE #Trading
0 · Reply
Quantumup
Quantumup Aug. 19 at 11:20 AM
BMO Capital🏁 $BCAX and said -- We are initiating coverage of Bicara Therapeutics with an Outperform rating and $35 target price. MRUS - $GMAB $LLY MRK BMY AZN INCY BMO Capital added—Bicara's bispecific, ficerafusp alfa, is a differentiated HNSCC asset with the potential to deliver broader, deeper, and more durable responses. The pivotal FORTIFI-HN01 interim analysis in mid-2027 is the key value inflection point, wherein a clear translation of strong Ph 1b activity indicates a strong market positioning, paving a path to accelerated approval in 2028 for a ~$2 billion peak sales opportunity. Other solid tumor opportunities, including mCRC, can provide additional upside potential.
0 · Reply
LLYBULL
LLYBULL Aug. 19 at 11:19 AM
$LLY Looks like LLY will be making new All Time Highs today! Go LLY, Fly like an Eagle!
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 19 at 10:38 AM
Novo Nordisk Begins New Study Testing Smaller Doses Of Blockbuster Wegovy – A Look At Some Key Highlights $NVO $LLY $OZEM https://stocktwits.com/news/equity/markets/novo-nordisk-looks-to-expand-wegovy-pill-push-with-lower-dose-study/cZYdgkhRJkA
0 · Reply
ChristineMartinez757
ChristineMartinez757 Aug. 19 at 9:15 AM
$HGRAF $KORU $LLY $HIMS HGRAF remains highly speculative, KORU remains speculative and execution-dependent, Eli Lilly benefits from strong obesity and diabetes-drug demand, and Hims & Hers benefits from digital-health adoption. I'm watching liquidity, prescription growth, customer additions, regulatory developments, and margins.
0 · Reply
WalterLind399
WalterLind399 Aug. 19 at 9:10 AM
$SGML $STLA $LLY $XLE Sigma Lithium remains tied to lithium development, Stellantis remains focused on global auto demand, Eli Lilly benefits from obesity and diabetes-drug demand, and XLE provides diversified energy exposure. I'm watching lithium prices, vehicle volumes, prescription growth, oil prices, and margins.
0 · Reply
TamiDungan690
TamiDungan690 Aug. 19 at 7:12 AM
$SGML $STLA $LLY $XLE Sigma Lithium remains tied to lithium development, Stellantis remains focused on global auto demand, Eli Lilly benefits from obesity and diabetes-drug demand, and XLE provides diversified energy exposure. I'm watching lithium prices, vehicle volumes, prescription growth, oil prices, and margins.
1 · Reply
RaulCole522
RaulCole522 Aug. 19 at 7:09 AM
$HGRAF $KORU $LLY $HIMS HGRAF remains highly speculative, KORU remains speculative and execution-dependent, Eli Lilly benefits from strong obesity and diabetes-drug demand, and Hims & Hers benefits from digital-health adoption. I'm watching liquidity, prescription growth, customer additions, regulatory developments, and margins.
0 · Reply
Johnny_Lever
Johnny_Lever Aug. 19 at 5:55 AM
$LLY Getting ready to re-test that ATH.
0 · Reply
yatch05
yatch05 Aug. 19 at 5:16 AM
$LLY new all time high by friday. let's go!
0 · Reply
RockyTSTH
RockyTSTH Aug. 19 at 5:03 AM
$LLY - Stock close to all time highs and resistance zone. $1235 break we can see $1250. bigger breakout above that. high watch for call if that level breaks for a move towards $1300 and $1385. Stock is decent at the indicator level.
0 · Reply
discussionbo7
discussionbo7 Aug. 19 at 3:20 AM
$INTU $NOW $LLY $MRNA we about to go higher
0 · Reply
ripster47
ripster47 Aug. 19 at 12:02 AM
Trading Top Day2 Plays Long Setups $AAOI & $LLY Watch the video to learn how to trade these repeatable Day 2 long setups 🎯 https://x.com/TENETTRADEGROUP/status/2089865049334747354?s=20
0 · Reply
MaverikIT
MaverikIT Aug. 18 at 11:11 PM
@WAJeff @cynicaloptimist @BustaCapital @Jblack500 @IsabellaDC @No_Face_character $LLY - nice girl got her hair$ done @ $ULTA $AXON shorts got taserized and off to $HCA or $THC
1 · Reply
parcha
parcha Aug. 18 at 10:03 PM
$VHT $XLV $LLY $JNJ Health care, biotech stocks climb to all-time highs Tuesday Health care and biotechnology stocks climbed to all-time highs Tuesday as investors searched for pockets of strength in the market beyond tech. The $44 billion State Street Health Care Select Sector SPDR ETF, made up of 62 stocks, reached a record. The fund’s total return over the past three months, including reinvested dividends, is 15.6% versus 4.8% for the S&P 500. The fund consists of 62 stocks, with Eli Lilly and Johnson & Johnson comprising 26% of the portfolio. The $19 billion Vanguard Health Care Index Fund also rose to a record, bringing its three-month total return to 16.6%. The fund contains 415 stocks and Lilly and J&J take up 22.2% of the total. https://www.cnbc.com/2026/08/17/stock-market-today-live-updates.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension
0 · Reply
Themadogtrader
Themadogtrader Aug. 18 at 9:58 PM
$LLY $LLYX fart
0 · Reply
LLYBULL
LLYBULL Aug. 18 at 9:56 PM
$LLY What a nice run over last 1 year, another easy 15% in-store till year-end!
0 · Reply
LLYBULL
LLYBULL Aug. 18 at 9:44 PM
$LLY GuruFocus is saying LLY's intrinsic value at this stage is $1510, so around 20% discount!
0 · Reply
dabz68
dabz68 Aug. 18 at 9:34 PM
$LLY only green in the portfolio today 🤦‍♂️
0 · Reply
LLYBULL
LLYBULL Aug. 18 at 9:33 PM
$LLY Good finish today, 2.2x Healthcare Index! Hope Technology to Healthcare rotation trend remains intact!
0 · Reply
btcbear
btcbear Aug. 18 at 8:58 PM
$LLY $VOO $VTV 88% of my portfolio the remaining 12% CASH
0 · Reply